Side Effects of Weight Loss Injections in Australia: The Honest Guide — Weight Loss GP Australia article
· Updated 01 May 2026

Side Effects of Weight Loss Injections in Australia: The Honest Guide

Key Takeaways

A plain-language guide to the side effects of Ozempic, Wegovy and Mounjaro — which are common and manageable, which are rare but serious, and what to do about them.

The Honest Guide to Side Effects of Weight Loss Injections in Australia

Most resources on side effects of weight loss injections fall into one of two camps: medical information sheets that list every possible adverse event in clinical language, or promotional content that downplays everything. Neither is particularly useful for someone trying to decide whether to start treatment or manage the side effects they're already experiencing.

This guide covers the side effects of GLP-1 weight loss injections — Ozempic, Wegovy, and Mounjaro — in plain language, including which are common and manageable, which are rare but serious, and what the TGA has specifically flagged for Australians to know.

The Most Common Side Effects: Gastrointestinal

The most common side effects of all three medications are gastrointestinal, and this is not a coincidence — it follows directly from how they work. GLP-1 receptor agonists slow gastric emptying (the rate at which food moves from the stomach into the intestine). This is central to how they produce satiety — but it also means the stomach and gut are operating differently than they're used to, particularly early in treatment.

The most commonly reported gastrointestinal side effects are:

  • Nausea — the most common, reported by 30–50% of patients at some point during treatment. Usually worst in the first 4–8 weeks and with each dose increase.
  • Vomiting — less common than nausea; typically accompanies significant nausea episodes rather than occurring independently.
  • Diarrhoea — reported by approximately 20–30% of patients; can occur at any point but is most common early in treatment.
  • Constipation — counterintuitively, some patients experience constipation rather than diarrhoea; gastric slowing can reduce bowel movement frequency.
  • Abdominal discomfort — bloating, fullness, or generalised stomach discomfort, especially after eating.

Why Are These Side Effects Worst at the Start?

GLP-1 medications are introduced at a low dose and increased gradually (titrated) specifically to allow the body to adapt. The side effects follow a predictable pattern: worst during the first weeks of each new dose, improving significantly as the body adjusts.

Want expert GP guidance before starting?

A thorough GP assessment is the best way to understand which medication suits your health profile. Bulk billed, from home.

Request an Appointment

The standard titration schedules for each medication are designed with this in mind:

  • Wegovy: Starts at 0.25mg/week, increases every 4 weeks over ~20 weeks to the 2.4mg maintenance dose
  • Ozempic: Starts at 0.25mg/week, increases at 4-week intervals
  • Mounjaro: Starts at 2.5mg/week, increases every 4 weeks — the slowest escalation of the three

If side effects at any dose are severe, your GP can slow the escalation — keeping you at a lower dose for longer before increasing. This is standard practice and does not mean the medication isn't working.

Practical Tips for Managing Nausea

  • Eat smaller portions more frequently rather than large meals
  • Avoid high-fat, greasy, or very spicy foods — these slow gastric emptying further
  • Eat slowly and stop when you feel full (the medication amplifies satiety signals)
  • Stay well hydrated
  • Inject on the same day each week — some patients find injecting before bed reduces perceived nausea
  • Avoid eating immediately before or after injection

Less Common but Notable Side Effects

  • Headache: Reported by some patients, particularly early in treatment. Usually mild and transient.
  • Fatigue: Some patients report lower energy levels, particularly during the initial weeks.
  • Dizziness: Occasionally reported, possibly related to reduced caloric intake or hydration.
  • Injection site reactions: Mild redness, itching, or bruising at the injection site. Rotating injection sites reduces this.
  • Hair thinning: Some patients report temporary hair shedding (telogen effluvium) associated with rapid weight loss — this is a general effect of significant weight loss rather than specific to these medications, and typically resolves.
  • Muscle loss: Rapid weight loss can include some lean muscle mass loss. Adequate protein intake and resistance exercise are recommended alongside treatment.

Rare but Serious Side Effects

Pancreatitis

Inflammation of the pancreas is a rare but serious potential adverse effect. Symptoms include severe, persistent abdominal pain, often radiating to the back. If you experience this, stop the medication and seek urgent medical care. Patients with a history of pancreatitis should discuss this risk with their GP before starting.

Gallbladder Problems

GLP-1 medications are associated with an increased risk of gallstones (cholelithiasis) and gallbladder inflammation (cholecystitis), likely related to rapid weight loss and changes in bile composition. This risk is relatively low but worth noting for patients with pre-existing gallbladder issues.

Thyroid C-Cell Tumours

In rodent studies at high doses, GLP-1 receptor agonists were associated with thyroid C-cell tumours. The relevance to humans is uncertain — these tumours have not been found to occur at higher rates in humans in post-marketing surveillance to date. However, patients with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome should not use these medications.

What the TGA Has Flagged for Australians

The TGA's product information for Ozempic, Wegovy, and Mounjaro available in Australia includes standard warnings consistent with international labelling. Key Australian-specific notes:

  • These medications must be prescribed by a registered medical practitioner
  • Compounded semaglutide (from compounding pharmacies) is not TGA-approved and the TGA has taken active steps to restrict its supply — only use TGA-registered products
  • Regular follow-up with your prescribing GP is expected and important

When to Contact Your GP

Contact your prescribing GP or seek medical attention if you experience:

  • Severe, persistent vomiting or inability to keep fluids down
  • Severe abdominal pain (possible pancreatitis)
  • Signs of allergic reaction (rash, swelling, difficulty breathing)
  • A lump or swelling in the neck (possible thyroid concern)
  • Any side effect that significantly impacts your daily functioning

Start your weight loss journey with proper GP support.

The best way to manage side effects is with an experienced GP monitoring your progress. Request a bulk billed telehealth appointment.

Book a Consultation